Abstract
Recent studies have implicated mitochondrial DNA mutations in tumor progression. In this chapter, we provide a review of the studies reporting on mitochondrial DNA mutations and their possible contributions to carcinogenesis. We propose a revised, practical definition for mitochondrial sequence diversity that accounts for observed thresholds found in mutation detection technologies and mitochondrial pathophysiology. Additionally, we describe current and prior efforts to identify somatic mutations in cancer and the challenges unique to mitochondrial DNA mutation analysis. We discuss the mechanisms that may generate these mutations, as well as the spectrum of observed physiological changes in cancer which they produce. Finally, we consider the utility of mitochondrial mutations as a sensitive biomarker in cancer diagnosis, disease prognosis, and patient outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abu-Amero K et al (2005) High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines. Oncogene 24(8):1455–1460
Alonso A et al (1997) Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. Electrophoresis 18(5):682–685
Backer JM et al (1980) Mitochondrial DNA is a major cellular target for a dihydrodiol-epoxide derivative of benzo[a]pyrene. Science 209:297–299
Backer JM et al (1982) Interaction of benzo(a)pyrene and its dihydrodiol-epoxide derivative with nuclear and mitochondrial DNA in C3h10t½ cell cultures. Cancer Res 42(7):2764–2769
Bandelt H et al (2009) Contamination and sample mix-up can best explain some patterns of mtDNA instabilities in buccal cells and oral squamous cell carcinoma. BMC Cancer 9:113
Berneburg M et al (1999) Singlet oxygen mediates the UVA-induced generation of the photoaging-associated mitochondrial common deletion. J Biol Chem 274(22):15345–15349
Bi R et al (2011) Rapid identification of mtDNA somatic mutations in gastric cancer tissues based on the mtDNA phylogeny. Mutat Res 709–710:15–20
Brandon M et al (2006) Mitochondrial mutations in cancer. Oncogene 25(34):4647–4662
Carew JS et al (2003) Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Leukemia 17(8):1437–1447
Challen C et al (2011) Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility. Br J Cancer 104(8):1319–1324
Chen T et al (2011) The mitochondrial DNA 4,977-Bp deletion and its implication in copy number alteration in colorectal cancer. BMC Med Genet 12:8
Coller H et al (2001) High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 28(2):147–150
Corona P et al (2001) A novel mtDNA mutation in the Nd5 subunit of complex I in two MELAS patients. Ann Neurol 49(1):106–110
Costa-Guda J et al (2007) Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomas. BMC Endocr Disord 7:8
Crick FHC (1966) Codon—anticodon pairing: the wobble hypothesis. J Mol Biol 19(2):548–555
Dahl H-HM (1998) Getting to the nucleus of mitochondrial disorders: identification of respiratory chain–enzyme genes causing Leigh syndrome. Am J Hum Genet 63(6):1594–1597
Dasgupta S et al (2010) Mitochondrial DNA mutation in normal margins and tumors of recurrent head and neck squamous cell carcinoma patients. Cancer Prev Res 3(9):1205–1211
Ding Z et al (2010) Analysis of mitochondrial DNA mutations in D-loop region in thyroid lesions. Biochim Biophys Acta Gen Subj 1800(3):271–274
Elliott HR et al (2008) Pathogenic mitochondrial DNA mutations Are common in the general population. Am J Hum Genet 83(2):254–260
Ericson NG et al (2012) Decreased mitochondrial DNA mutagenesis in human colorectal cancer. PLoS Genet 8(6), e1002689
Fliss M et al (2000) Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287(5460):2017–2019
Frederico LA et al (1990) A sensitive genetic assay for the detection of cytosine deamination: determination of rate constants and the activation energy. Biochemistry 29(10):2532–2537
Gasparre G et al (2007) Disruptive mitochondrial DNA mutations in complex I subunits Are markers of oncocytic phenotype in thyroid tumors. Proc Natl Acad Sci U S A 104(21):9001–9006
Gasparre G et al (2008) Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma. Hum Mol Genet 17(7):986–995
Gasparre G et al (2011) A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene Mtnd1, an oncojanus function. Cancer Res 71(19):6220–6229
Gekeler J et al (2009) Clonal expansion of different mtDNA variants without selective advantage in solid tumors. Mutat Res 662(1-2):28–32
Gogvadze V et al (2009) Mitochondria as targets for cancer chemotherapy. Semin Cancer Biol 19(1):57–66
Gomez-Zaera M et al (2006) Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients. Mutat Res 595(1-2):42–51
Greaves LC et al (2014) Clonal expansion of early to mid-life mitochondrial DNA point mutations drives mitochondrial dysfunction during human ageing. PLoS Genet 10(9), e1004620
Greenman C et al (2006) Statistical analysis of pathogenicity of somatic mutations in cancer. Genetics 173(4):2187–2198
Guerra F et al (2012) Mitochondrial DNA mutation in serous ovarian cancer: implications for mitochondria-coded genes in chemoresistance. J Clin Oncol 30(36):e373–e378
Habano W et al (1999) Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int J Cancer 83(5):625–629
Hanahan D et al (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
He L et al (2003) Somatic mitochondrial DNA mutations in adult-onset leukaemia. Leukemia 17(12):2487–2491
He Y et al (2010) Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 464(7288):610–614
Higuchi M et al (2005) Mitochondrial DNA determines androgen dependence in prostate cancer cell lines. Oncogene 25(10):1437–1445
Horton TM et al (1996) Novel mitochondrial DNA deletion found in a renal cell carcinoma. Genes Chromosomes Cancer 15(2):95–101
Hu J et al (2013) Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nat Biotechnol 31(6):522–529
Hung WY et al (2010) Somatic mutations in mitochondrial genome and their potential roles in the progression of human gastric cancer. Biochim Biophys Acta 1800(3):264–270
Imanishi H et al (2011) Mitochondrial DNA mutations regulate metastasis of human breast cancer cells. PLoS One 6(8), e23401
Iommarini L et al (2013) Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment. Hum Mol Genet 23(6):1453–1466
Ishikawa K et al (2008) Ros-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320(5876):661–664
Jandova J et al (2012) Somatic alterations in mitochondrial DNA produce changes in cell growth and metabolism supporting a tumorigenic phenotype. Biochim Biophys Acta (BBA)—Mol Basis Dis 1822(2):293–300
Jerónimo C et al (2001) Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20(37):5195–5198
Jin X et al (2007) Relationship between mitochondrial DNA mutations and clinical characteristics in human lung cancer. Mitochondrion 7(5):347–353
Ju YS et al. (2014) Origins and Functional Consequences of Somatic Mitochondrial DNA Mutations in Human Cancer. Elife. doi: 10.7554/eLife.02935.
Kamalidehghan B et al (2013) Pitfalls for common mitochondrial DNA deletion (DeltamtDNA4977) as a biomarker of cancer. Arch Med Res 44(1):79–80
Kassauei K et al (2006) Mitochondrial DNA mutations in pancreatic cancer. Int J Gastrointest Cancer 37(2-3):57–64
Kloss-Brandstatter A et al (2010) Somatic mutations throughout the entire mitochondrial genome Are associated with elevated Psa levels in prostate cancer patients. Am J Hum Genet 87(6):802–812
Kulawiec M et al (2010) Generation, function, and prognostic utility of somatic mitochondrial DNA mutations in cancer. Environ Mol Mutagen 51(5):427–439
Lai CH et al (2013) Clinical significance in oral cavity squamous cell carcinoma of pathogenic somatic mitochondrial mutations. PLoS One 8(6), e65578
Larman TC et al (2012) Spectrum of somatic mitochondrial mutations in five cancers. Proc Natl Acad Sci 109(35):14087–14091
LeDoux SP et al (1992) Repair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells. Carcinogenesis 13(11):1967–1973
Lee H-C et al (2004) Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res 547(1–2):71–78
Lee HC et al (2014) Somatic alterations in mitochondrial DNA and mitochondrial dysfunction in gastric cancer progression. World J Gastroenterol 20(14):3950–3959
Lemarie A et al (2011) Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer[quest]. Oncogene 30(38):3985–4003
Li LH et al (2014) Detection of mitochondrial DNA mutations by high-throughput sequencing in the blood of breast cancer patients. Int J Mol Med 33(1):77–82
Lièvre A et al (2005) Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol 23(15):3517–3525
Liu V et al (2001) High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 61(16):5998–6001
Mambo E et al (2003) Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations. Proc Natl Acad Sci 100(4):1838–1843
Matsuyama W et al (2003) Mitochondrial DNA mutation correlates with stage progression and prognosis in non-small cell lung cancer. Hum Mutat 21(4):441–443
Maximo V et al (2002) Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors. Am J Pathol 160(5):1857–1865
Maybury BD (2013) Mitochondrial DNA damage is uncommon in cancer but can promote aggressive behaviour. Anticancer Res 33(9):3543–3552
Mayr JA et al (2008) Loss of complex I Due to mitochondrial DNA mutations in renal oncocytoma. Clin Cancer Res 14(8):2270–2275
McFarland R et al (2004) Assigning pathogenicity to mitochondrial trna mutations: when ‘definitely Maybe’ is Not good enough. Trends Genet 20(12):591–596
McMahon S et al (2014) Mutational patterns in the breast cancer mitochondrial genome, with clinical correlates. Carcinogenesis 35(5):1046–1054
Melton T, Holland C, Holland M (2012) Forensic mitochondrial DNA analysis: current practice and future potential. Forensic Sci Rev 24(101):102–122
Miller KWP et al (1996) A concordance of nucleotide substitutions in the first and second hypervariable segments of the human mtDNA control region. Int J Legal Med 109(3):107–113
Mishmar D et al (2003) Natural selection shaped regional mtDNA variation in humans. Proc Natl Acad Sci U S A 100(1):171–176
Mita S et al (1988) Resistance of Hela cell mitochondrial DNA to mutagenesis by chemical carcinogens. Cancer Res 48(16):4578–4583
Mitomap (2014) A human mitochondrial genome database. http://www.mitomap.org. Accessed 31 Oct 2014
Montero AJ et al (2011) Cellular redox pathways as a therapeutic target in the treatment of cancer. Drugs 71(11):1385–1396
Murata T et al (1990) Preferential binding of cisplatin to mitochondrial DNA and suppression of Atp generation in human malignant melanoma cells. Biochem Int 20(5):949–955
Nekhaeva E et al (2002) Clonally expanded mtDNA point mutations are abundant in individual cells of human tissues. Proc Natl Acad Sci 99(8):5521–5526
Nie H et al (2013) Mitochondrial common deletion, a potential biomarker for cancer occurrence, is selected against in cancer background: a meta-analysis of 38 studies. PLoS One 8(7), e67953
Nik-Zainal S et al (2012) Mutational processes molding the genomes of 21 breast cancers. Cell 149(5):979–993
Nishikawa M et al (2001) Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res 61(5):1843–1845
Ohta S (2006) Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs. Oncogene 25(34):4768–4776
Palorini R et al (2013) Mitochondrial complex I inhibitors and forced oxidative phosphorylation synergize in inducing cancer cell death. Int J Cell Biol 2013:243876
Park JS et al (2009) A heteroplasmic, Not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis Via alteration in reactive oxygen species generation and apoptosis. Hum Mol Genet 18(9):1578–1589
Parrella P et al (2001) Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res 61(20):7623–7626
Payne BA et al (2013) Universal heteroplasmy of human mitochondrial DNA. Hum Mol Genet 22(2):384–390
Petros J et al (2005) MtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A 102(3):719–724
Polyak K et al (1998) Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20(3):291–293
Prior SL et al (2006) Mitochondrial DNA mutations in oral squamous cell carcinoma. Carcinogenesis 27(5):945–950
Qian W et al (2005) Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell death. Am J Physiol Cell Physiol 289(6):C1466–C1475
Ruiz-Pesini E et al (2004) Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 303(5655):223–226
Salas A et al (2005) A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med 2(11), e296
Santorelli FM et al (1993) The mutation at Nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol 34(6):827–834
Sharma LK et al (2011) Mitochondrial respiratory complex I dysfunction promotes tumorigenesis through Ros alteration and Akt activation. Hum Mol Genet 20(23):4605–4616
Shidara Y et al (2005) Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 65(5):1655–1663
Stafford P et al (2010) The pattern of natural selection in somatic cancer mutations of human mtDNA. J Hum Genet 55(9):605–612
Stewart JB et al (2008) Strong purifying selection in transmission of mammalian mitochondrial DNA. PLoS Biol 6(1), e10
Stoneking M et al (1991) Population variation of human mtDNA control region sequences detected by enzymatic amplification and sequence-specific oligonucleotide probes. Am J Hum Genet 48(2):370–382
Stumpf JD et al (2014) Mms exposure promotes increased mtDNA mutagenesis in the presence of replication-defective disease-associated DNA polymerase Γ variants. PLoS Genet 10(10), e1004748
Taira M et al (1983) Tumor-associated mutations of Rat mitochondrial transfer Rna genes. Nucleic Acids Res 11(6):1635–1644
Tan D et al (2008) Associations between cigarette smoking and mitochondrial DNA abnormalities in buccal cells. Carcinogenesis 29(6):1170–1177
Taylor RW et al (2003) Mitochondrial DNA Mutations in Human Colonic Crypt Stem Cells. J Clin Invest 112(9):1351–1360
Taylor SD et al (2013) Targeted enrichment and high-resolution digital profiling of mitochondrial DNA deletions in human brain. Aging Cell 13(1):29–38
Tseng LM et al (2011) Somatic mutations of the mitochondrial genome in human breast cancers. Genes Chromosomes Cancer 50(10):800–811
Vermulst M et al (2008) Quantification of random mutations in the mitochondrial genome. Methods 46(4):263–268
Warburg O (1956) On the origin of cancer cells. Science 123(3191):309–314
Warburg O, Posener K, Negelein E (1930) Ueber Den stoffwechsel Der tumoren. Biochem Z 152:319–344
Wisnovsky SP et al (2013) Targeting mitochondrial DNA with a platinum-based anticancer agent. Chem Biol 20(11):1323–1328
Wu C-W et al (2005) Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes Chromosom Cancer 44(1):19–28
Yamada S et al (2006) Correlation between copy number of mitochondrial DNA and clinico‐pathologic parameters of hepatocellular carcinoma. Eur J Surg Oncol 32(3):303–307
Yang Ai SS et al (2013) Mitochondrial DNA mutations in exhaled breath condensate of patients with lung cancer. Respir Med 107(6):911–918
Yang Z et al (2006) Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis. Clin Cancer Res 12(19):5817–5825
Ye K et al (2014) Extensive pathogenicity of mitochondrial heteroplasmy in healthy human individuals. Proc Natl Acad Sci 111(29):10654–10659
Yeh J et al (2000) Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene 19(16):2060–2066
Yin P et al (2010) Somatic mutations of mitochondrial genome in hepatocellular carcinoma. Mitochondrion 10(2):174–182
Yoneda M et al (1995) Heteroplasmic mitochondrial trna(Lys) mutation and its complementation in merrf patient-derived mitochondrial transformants. Muscle Nerve Suppl 3:S95–S101
Yu M (2011) Generation, function and diagnostic value of mitochondrial DNA copy number alterations in human cancers. Life Sci 89(3–4):65–71
Yu M et al (2007) Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients. IUBMB Life 59(7):450–457
Yu M et al (2009) Mitochondrial DNA depletion promotes impaired oxidative status and adaptive resistance to apoptosis in T47d breast cancer cells. Eur J Cancer Prev 18(6):445–457
Zang ZJ et al (2012) Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet 44(5):570–574
Zhu W et al (2005) Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis 26(1):145–152
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Valente, W.J., Bielas, J.H. (2016). Mitochondrial Mutagenesis in Cancer. In: Hockenbery, D. (eds) Mitochondria and Cell Death. Cell Death in Biology and Diseases. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3612-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3612-0_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3610-6
Online ISBN: 978-1-4939-3612-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)